Highlights
- Lacking pediatric data, pediatric heart failure treatment optimization has not had guidelines with which to provide GDMT
- We created multi-center Consensus-Directed Medical Therapy (CDMT) recommendations for pediatric heart failure
- Real world optimization of oral pediatric heart failure therapies lags far behind the CDMT
- There remains significant room for improvement in pediatric heart failure medication optimization
This ACTION study was published in the Journal of Cardiac Failure on November 19, 2024. Congratulations to the authors:
- D Nandi
- LK Wright
- J Sublett-Smith
- A Brax
- N Bansal
- CS Almond
- E Azeka
- R Butts
- S Chen
- J Conway
- C Cunningham
- LA Fisher
- EK Hall
- T Hunter
- R Kobayashi
- D Patterson
- DM Peng
- KE Simpson
- TD Ryan
- JA Spinner
- B Wisotzkey
- S Zangwill
- RJ Gajarski
- M O’Connor
CITATION
D Nandi, LK Wright, J Sublett-Smith, A Brax, N Bansal, CS Almond, E Azeka, R Butts, S Chen, J Conway, C Cunningham, LA Fisher, EK Hall, T Hunter, R Kobayashi, D Patterson, DM Peng, KE Simpson, TD Ryan, JA Spinner, B Wisotzkey, S Zangwill, RJ Gajarski, M O’Connor, Suboptimal Titration of Heart Failure Medications in Pediatric Patients: Baseline Data from ACTION, Journal of Cardiac Failure (2024), doi: https://doi.org/10.1016/j.cardfail.2024.10.445
